SG11202009826PA - Method for large-scale production of lentivirus by using gmp-level serum-free suspension cells - Google Patents

Method for large-scale production of lentivirus by using gmp-level serum-free suspension cells

Info

Publication number
SG11202009826PA
SG11202009826PA SG11202009826PA SG11202009826PA SG11202009826PA SG 11202009826P A SG11202009826P A SG 11202009826PA SG 11202009826P A SG11202009826P A SG 11202009826PA SG 11202009826P A SG11202009826P A SG 11202009826PA SG 11202009826P A SG11202009826P A SG 11202009826PA
Authority
SG
Singapore
Prior art keywords
lentivirus
gmp
scale production
suspension cells
free suspension
Prior art date
Application number
SG11202009826PA
Other languages
English (en)
Inventor
Yi Hong
Ting Yan
Jiangguo Ying
Haojie Zhang
Luyi Zhang
Li Zhang
Original Assignee
Cellular Biomedicine Group Hk Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cellular Biomedicine Group Hk Ltd filed Critical Cellular Biomedicine Group Hk Ltd
Publication of SG11202009826PA publication Critical patent/SG11202009826PA/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D15/00Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08Selective adsorption, e.g. chromatography
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12MAPPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M47/00Means for after-treatment of the produced biomass or of the fermentation or metabolic products, e.g. storage of biomass
    • C12M47/02Separating microorganisms from the culture medium; Concentration of biomass
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12MAPPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M47/00Means for after-treatment of the produced biomass or of the fermentation or metabolic products, e.g. storage of biomass
    • C12M47/12Purification
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86Viral vectors
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00Reverse transcribing RNA viruses
    • C12N2740/00011Details
    • C12N2740/10011Retroviridae
    • C12N2740/15011Lentivirus, not HIV, e.g. FIV, SIV
    • C12N2740/15041Use of virus, viral particle or viral elements as a vector
    • C12N2740/15043Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00Reverse transcribing RNA viruses
    • C12N2740/00011Details
    • C12N2740/10011Retroviridae
    • C12N2740/15011Lentivirus, not HIV, e.g. FIV, SIV
    • C12N2740/15051Methods of production or purification of viral material
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00Reverse transcribing RNA viruses
    • C12N2740/00011Details
    • C12N2740/10011Retroviridae
    • C12N2740/16011Human Immunodeficiency Virus, HIV
    • C12N2740/16041Use of virus, viral particle or viral elements as a vector
    • C12N2740/16043Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00Reverse transcribing RNA viruses
    • C12N2740/00011Details
    • C12N2740/10011Retroviridae
    • C12N2740/16011Human Immunodeficiency Virus, HIV
    • C12N2740/16051Methods of production or purification of viral material

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Sustainable Development (AREA)
  • Analytical Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
SG11202009826PA 2018-03-29 2019-03-28 Method for large-scale production of lentivirus by using gmp-level serum-free suspension cells SG11202009826PA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN201810273392.7A CN110317791A (zh) 2018-03-29 2018-03-29 Gmp级无血清悬浮细胞大规模生产慢病毒的方法
PCT/CN2019/080215 WO2019184996A1 (zh) 2018-03-29 2019-03-28 Gmp级无血清悬浮细胞大规模生产慢病毒的方法

Publications (1)

Publication Number Publication Date
SG11202009826PA true SG11202009826PA (en) 2020-11-27

Family

ID=68058573

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11202009826PA SG11202009826PA (en) 2018-03-29 2019-03-28 Method for large-scale production of lentivirus by using gmp-level serum-free suspension cells

Country Status (8)

Country Link
US (2) US11845962B2 (ko)
EP (1) EP3778880A4 (ko)
JP (2) JP2021519108A (ko)
KR (1) KR20200136463A (ko)
CN (1) CN110317791A (ko)
AU (1) AU2019241301A1 (ko)
SG (1) SG11202009826PA (ko)
WO (1) WO2019184996A1 (ko)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110317791A (zh) * 2018-03-29 2019-10-11 西比曼生物科技(香港)有限公司 Gmp级无血清悬浮细胞大规模生产慢病毒的方法
CN110894494B (zh) * 2019-11-22 2022-09-27 广西梧州制药(集团)股份有限公司 一种大规模高密度悬浮培养293细胞高产腺病毒的方法
CN113832112A (zh) * 2020-06-24 2021-12-24 重庆精准生物技术有限公司 一种制备慢病毒的混合方法及混合系统
CN113265425A (zh) * 2021-05-08 2021-08-17 苏州博腾生物制药有限公司 基于悬浮细胞的car-cd19慢病毒制备工艺
CN114990077A (zh) * 2022-08-01 2022-09-02 深圳市先康达生命科学有限公司 一种慢病毒包装与纯化方法

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002348151A1 (en) 2001-11-05 2003-05-19 Genvec, Inc. Viral vector production methods and compositions
US20030175688A1 (en) 2002-03-15 2003-09-18 Rukmini Pennathur-Das Method for the purification and production of oncolytic adenoviruses
WO2007095336A2 (en) 2006-02-15 2007-08-23 The Immune Response Corporation Production of hiv
EP2007883B1 (en) 2006-04-20 2011-12-28 Wyeth LLC Purification processes for isolating purified vesicular stomatitis virus from cell culture
AU2008340319A1 (en) 2007-12-21 2009-07-02 Wyeth Llc Genetically modified attenuated vesicular stomatitis virus, compositions and methods of use thereof
CA2742474C (en) 2008-11-03 2016-05-31 Crucell Holland B.V. Method for the production of adenoviral vectors
PT2782997T (pt) 2011-11-24 2018-04-09 Genethon Sistema de produção de vetor lentiviral escalável compatível com aplicações farmacêuticas industriais
EP2682168A1 (en) 2012-07-02 2014-01-08 Millipore Corporation Purification of biological molecules
CN103881984A (zh) * 2013-12-06 2014-06-25 深圳市赛百诺基因技术有限公司 无血清悬浮细胞生产重组腺病毒的方法及其药品制剂生产方法
FR3014901B1 (fr) 2013-12-17 2017-06-09 Genethon Procede de purification de virus ou vecteurs viraux enveloppes
CN104371982A (zh) 2014-10-21 2015-02-25 武汉维诺赛生物技术有限公司 一种慢病毒的纯化方法
EP3054007A1 (en) 2015-02-09 2016-08-10 Institut National De La Sante Et De La Recherche Medicale (Inserm) Recombinant adeno-associated virus particle purification comprising an immuno-affinity purification step
CN107043784A (zh) * 2016-02-05 2017-08-15 上海吉凯基因化学技术有限公司 一种慢病毒载体的制备方法
CN107523555A (zh) * 2016-06-22 2017-12-29 武汉光谷人福生物医药有限公司 获得病毒的方法
CN107841482B (zh) * 2016-09-21 2021-07-27 上海倍谙基生物科技有限公司 Mdck细胞无血清悬浮培养技术生产h9亚型流感疫苗
CN106434571A (zh) * 2016-10-19 2017-02-22 深圳源兴基因技术有限公司 一种wave无血清培养悬浮细胞制备重组腺病毒的方法
CN106474466B (zh) 2016-12-07 2018-04-13 申联生物医药(上海)股份有限公司 一种口蹄疫疫苗的制备方法
CN107384877B (zh) 2017-08-18 2020-09-08 深圳源兴基因技术有限公司 一种慢病毒的纯化方法
CN107630037A (zh) 2017-10-19 2018-01-26 和元生物技术(上海)股份有限公司 一种获得高纯度腺相关病毒载体的纯化工艺
CN110317832B (zh) 2018-03-28 2022-07-05 西比曼生物科技(香港)有限公司 Gmp级规模化制备重组慢病毒载体的纯化制剂的方法
CN110317791A (zh) * 2018-03-29 2019-10-11 西比曼生物科技(香港)有限公司 Gmp级无血清悬浮细胞大规模生产慢病毒的方法

Also Published As

Publication number Publication date
CN110317791A (zh) 2019-10-11
KR20200136463A (ko) 2020-12-07
WO2019184996A1 (zh) 2019-10-03
US20240060053A1 (en) 2024-02-22
US11845962B2 (en) 2023-12-19
JP2024075766A (ja) 2024-06-04
US20210363497A1 (en) 2021-11-25
EP3778880A1 (en) 2021-02-17
JP2021519108A (ja) 2021-08-10
EP3778880A4 (en) 2021-12-29
AU2019241301A1 (en) 2020-10-22

Similar Documents

Publication Publication Date Title
SG11202009826PA (en) Method for large-scale production of lentivirus by using gmp-level serum-free suspension cells
IL285816A (en) Methods for producing cloned plants
EP3256439A4 (en) Process for production of acrylic acid
MX2016012419A (es) Formas solidas de ibrutinib y procesos para la produccion de las mismas.
WO2016012445A3 (en) Process for the purification of poliovirus from cell cultures
IL274746A (en) A method for cell culture
EP3830280A4 (en) PROCESSES FOR THE PRODUCTION OF NEW DITERPEN FRAMEWORKS
GB201911958D0 (en) Methods of t cell production
IL280556A (en) Cell production method
HK1247849A1 (zh) 用於培養哺乳動物細胞的微載體、基質和支架及其製造方法
GB2593104B (en) System for optimization of hydrocarbon production
IL291365A (en) A method for predicting the production stability of cloned cell lines
GB201608060D0 (en) Method of culturing T cells
EP3587559A4 (en) MANUFACTURING METHOD FOR ARTIFICIAL PLURIPOTENT STEM CELLS
SG11202108435WA (en) Method for virus production
PL3755681T3 (pl) Sposób wytwarzania 4-boronofenyloalaniny
EP3569693A4 (en) METHOD OF PREPARING A CELL CULTURE
EP3133148A4 (en) Method for mass culturing photosynthetic microalgae by additionally supplying environmental water
EP3896155A4 (en) PRODUCTION PROCESS FOR GENOMEEDIT CELLS
SG11202011845XA (en) Production method for culture supernatant preparation
PL3766570T3 (pl) Sposób wytwarzania alkoksylanów
EP3717656C0 (en) METHOD FOR CULTIVATING MAMMALIAN CELLS
EP3863962C0 (en) PROCESS FOR PRODUCING HYDROGEN
HUE065644T2 (hu) Eljárás negatív elektróda elõállítására
EP3296390A4 (en) METHOD FOR THE PRODUCTION OF STEM CELL CLONES FOR INDUCING DIFFERENTIATION IN BODILY CELLS